814 (Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg)
Pill imprint 814 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.
Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 814
- Strength:
- 5 mg / 2.5 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anticholinergics/antispasmodics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Acella Pharmaceuticals LLC
More about chlordiazepoxide/clidinium
Consumer resources
- Chlordiazepoxide/clidinium
- Chlordiazepoxide and clidinium
- Chlordiazepoxide and clidinium (Advanced Reading)
- Other brands: Librax
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
